EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tertiary Lymphoid Structures in Human Melanoma: Molecular Mechanisms and Therapeutic Opportunities

Gelare Ghajar-Rahimi, Ishika Patel iD, Nabiha Yusuf iD

Cells · 04.09.2025 · 14 (17) · 1378

DOI: 10.3390/cells14171378 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 04.09.2025. Verfasst von Gelare Ghajar-Rahimi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Hauptthemen laut MEDLINE: Melanoma, Tertiary Lymphoid Structures. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tertiary lymphoid structures (TLSs) are ectopic lymphoid aggregates often found in chronic inflammatory conditions, including cancer. These structures, which share many cellular and functional features with secondary lymphoid organs, can profoundly influence the tumor microenvironment by promoting local anti-tumor immune activation. TLSs have been observed in various cancers, including melanoma, and are associated with improved responses to immunotherapy and clinical outcomes. However, our understanding of the molecular mechanisms underlying TLS formation and function remains incomplete. This review summarizes the current findings on TLSs in human melanoma, drawing from multiple studies to provide an updated overview. We discuss the cellular composition, spatial distribution, and genetic signatures of TLSs at different stages of melanoma pathogenesis and in subtypes including acral, uveal, and desmoplastic melanoma. Additionally, we examine the influence of tumor mutational burden (TMB) and complement activation on TLS formation, as well as the role of TLSs in immune checkpoint inhibitor therapy. We also highlight the potential of TLSs as indicators for disease progression and treatment response, and review preclinical strategies aimed at inducing TLSs to improve therapeutic outcomes. This synthesis aims to support ongoing research into the role of TLSs in melanoma immunobiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaTertiary Lymphoid StructuresHumansTumor MicroenvironmentImmunotherapy

Stichwörter der Autor:innen

acral melanomadesmoplastic melanomaimmune checkpoint inhibitorsimmunotherapymelanomatertiary lymphoid structuresuveal melanoma

Autor:innen und Institutionen

  • Department of Dermatology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

ORCID-Profile: Ishika Patel, Nabiha Yusuf

Zitieren

APA

Ghajar-Rahimi, G., Patel, I., & Yusuf, N. (2025). Tertiary Lymphoid Structures in Human Melanoma: Molecular Mechanisms and Therapeutic Opportunities. Cells, 14(17), 1378. https://doi.org/10.3390/cells14171378

Vancouver

Ghajar-Rahimi G, Patel I, Yusuf N. Tertiary Lymphoid Structures in Human Melanoma: Molecular Mechanisms and Therapeutic Opportunities. Cells. 2025;14(17):1378. doi:10.3390/cells14171378

BibTeX
@article{GhajarRahimi2025,
  author = {Ghajar-Rahimi, Gelare and Patel, Ishika and Yusuf, Nabiha},
  title = {Tertiary Lymphoid Structures in Human Melanoma: Molecular Mechanisms and Therapeutic Opportunities},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {17},
  pages = {1378},
  doi = {10.3390/cells14171378}
}
Kostenlos starten →